For anyone that missed it
2 points that stood out to me (they seem to be tempering market expectations)
- flexibility with product specifications
target concentrate was 6% (then mentioned 'still is') - then continues to say "not many of our competitors are punching out 6% - so there is opportunity to look at an alternative grade and get the benefit of recovery and cost".
- recoveries of >70% expected by Q4 2025
in other words, recoveries will be lower in the beginning, and for about a year or so
I felt like those 2 points were made so that the market isnt too disappointed when they release initial results as they go
I guess its to be expected, and thats why theres always mention of 'ramp up risks' etc.
For anyone that missed it2 points that stood out to me (they...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.5¢ |
Change
0.060(8.28%) |
Mkt cap ! $1.903B | |||
| Open | High | Low | Value | Volume |
| 76.5¢ | 79.5¢ | 74.5¢ | $19.01M | 24.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 46043 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.0¢ | 62337 | 7 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| LTR (ASX) Chart |